Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277


Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.

Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E.

J Natl Cancer Inst. 2000 Dec 20;92(24):2009-17.


Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.

Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, Teh CZ, Dreon DM, Paffenbarger RS Jr.

Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):735-41.


Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1262-9.


Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.

Bennett CL, Price DK, Kim S, Liu D, Jovanovic BD, Nathan D, Johnson ME, Montgomery JS, Cude K, Brockbank JC, Sartor O, Figg WD.

J Clin Oncol. 2002 Sep 1;20(17):3599-604.


Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males.

Lopez DS, Peskoe SB, Joshu CE, Dobs A, Feinleib M, Kanarek N, Nelson WG, Selvin E, Rohrmann S, Platz EA.

Cancer Causes Control. 2013 Apr;24(4):817-26. doi: 10.1007/s10552-013-0154-8. Epub 2013 Jan 25.


Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.

Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1107-10.


Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.

Wu AH, Whittemore AS, Kolonel LN, Stanczyk FZ, John EM, Gallagher RP, West DW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):533-8.


Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.

Gilligan T, Manola J, Sartor O, Weinrich SP, Moul JW, Kantoff PW.

Clin Prostate Cancer. 2004 Sep;3(2):98-103.


Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM Jr, Lucia MS, Kristal AR.

JAMA Oncol. 2015 Jun;1(3):342-9. doi: 10.1001/jamaoncol.2015.0513. Erratum in: JAMA Oncol. 2015 Jun;1(3):322.


Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A.

J Gen Intern Med. 2004 Feb;19(2):146-55.


Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.

Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR.

Eur Urol. 2015 Mar;67(3):451-7. doi: 10.1016/j.eururo.2014.03.026. Epub 2014 Apr 5.


Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada.

Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS.

Cancer Causes Control. 2002 Jun;13(5):471-82.


Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.

Zagars GK, Pollack A, Pettaway CA.

Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):517-23.


Association of African-American ethnic background with survival in men with metastatic prostate cancer.

Thompson I, Tangen C, Tolcher A, Crawford E, Eisenberger M, Moinpour C.

J Natl Cancer Inst. 2001 Feb 7;93(3):219-25.


Ultraviolet index and racial differences in prostate cancer incidence and mortality.

Taksler GB, Cutler DM, Giovannucci E, Smith MR, Keating NL.

Cancer. 2013 Sep 1;119(17):3195-203. doi: 10.1002/cncr.28127. Epub 2013 Jun 6.


Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL.

J Natl Cancer Inst. 2001 Mar 7;93(5):388-95.


Why do African-American men suffer more prostate cancer?

McIntosh H.

J Natl Cancer Inst. 1997 Feb 5;89(3):188-9. No abstract available.


Ethnicity and breast cancer: factors influencing differences in incidence and outcome.

Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R.

J Natl Cancer Inst. 2005 Mar 16;97(6):439-48.


Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP.

Cancer. 2005 Feb 1;103(3):538-45.


Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.

Hayn MH, Orom H, Shavers VL, Sanda MG, Glasgow M, Mohler JL, Underwood W 3rd.

Cancer. 2011 Oct 15;117(20):4651-8. doi: 10.1002/cncr.26103. Epub 2011 Mar 31.

Supplemental Content

Support Center